{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:37:54Z","timestamp":1772134674731,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1038\/nm0302-274","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:30:40Z","timestamp":1027657840000},"page":"274-281","source":"Crossref","is-referenced-by-count":403,"title":["Tumor-cell resistance to death receptor\u2013induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax"],"prefix":"10.1038","volume":"8","author":[{"given":"Heidi","family":"LeBlanc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Varfolomeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Totpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Morlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Schwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick","family":"Sinicropi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0302274_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305\u20131308 (1998).","journal-title":"Science"},{"key":"BFnm0302274_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(00)00003-9","volume":"102","author":"D Green","year":"2000","unstructured":"Green, D. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102, 1\u20134 (2000).","journal-title":"Cell"},{"key":"BFnm0302274_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li, H., Zhu, H., Xu, C.-J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway to apoptosis. Cell 94, 491\u2013501 (1998).","journal-title":"Cell"},{"key":"BFnm0302274_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","volume":"94","author":"X Luo","year":"1998","unstructured":"Luo, X., Budihardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481\u2013490 (1998).","journal-title":"Cell"},{"key":"BFnm0302274_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1074\/jbc.274.2.1156","volume":"274","author":"A Gross","year":"1999","unstructured":"Gross, A. et al. Caspase cleaved Bid targets mitochondria and is required for cytochrome c release, while Bcl-XL prevents this release but not tumor necrosis factor-R1\/Fas death. J. Biol. Chem. 274, 1156\u20131163 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnm0302274_CR6","doi-asserted-by":"publisher","first-page":"F21","DOI":"10.1084\/jem.192.8.F21","volume":"192","author":"S Roy","year":"2000","unstructured":"Roy, S. & Nicholson, D. Cross-talk in cell death signaling. J. Exp. Med. 192, F21\u2013F25 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm0302274_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1128\/MCB.20.3.929-935.2000","volume":"20","author":"R Eskes","year":"2000","unstructured":"Eskes, R., Desagher, S., Antonsson, B. & Martinou, J. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929\u2013935 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm0302274_CR8","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.14.16.2060","volume":"14","author":"M Wei","year":"2000","unstructured":"Wei, M. et al. tBID, a membrane targeted death ligand, oligomerizes Bak to release cytochrome c. Genes Dev. 14, 2060\u20132071 (2000).","journal-title":"Genes Dev."},{"key":"BFnm0302274_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/23730","volume":"400","author":"X-M Yin","year":"1999","unstructured":"Yin, X.-M. et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886\u2013891 (1999).","journal-title":"Nature"},{"key":"BFnm0302274_CR10","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1097-2765(00)00136-2","volume":"6","author":"T Lindsten","year":"2000","unstructured":"Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Molec. Cell 6, 1389\u20131399 (2000).","journal-title":"Molec. Cell"},{"key":"BFnm0302274_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"Wei, M.C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727\u2013730 (2001).","journal-title":"Science"},{"key":"BFnm0302274_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35037747","volume":"407","author":"DW Nicholson","year":"2000","unstructured":"Nicholson, D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810\u2013816 (2000).","journal-title":"Nature"},{"key":"BFnm0302274_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer, C., Kinzler, K. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643\u2013649 (1998).","journal-title":"Nature"},{"key":"BFnm0302274_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.275.5302.967","volume":"275","author":"N Rampino","year":"1997","unstructured":"Rampino, N. et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967\u2013969 (1997).","journal-title":"Science"},{"key":"BFnm0302274_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.290.5493.989","volume":"290","author":"L Zhang","year":"2000","unstructured":"Zhang, L., Yu, J., Park, B., Kinzler, K. & Vogelstein, B. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989\u2013992 (2000).","journal-title":"Science"},{"key":"BFnm0302274_CR16","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1073\/pnas.190210897","volume":"97","author":"Y Ionov","year":"2000","unstructured":"Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J.C. & Perucho, M. Mutational inactivation of the proapoptotic gene Bax confers selective advantage during tumor clonal evolution. Proc. Natl. Acad. Sci. USA 97, 10872\u201310877 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0302274_CR17","first-page":"675","volume":"377","author":"M Perucho","year":"1996","unstructured":"Perucho, M. Cancer of the microsatellite mutator phenotype. Biol. Chem. 377, 675\u2013684 (1996).","journal-title":"Biol. Chem."},{"key":"BFnm0302274_CR18","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"FC Kischkel","year":"1995","unstructured":"Kischkel, F.C. et al. Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579\u20135588 (1995).","journal-title":"EMBO J."},{"key":"BFnm0302274_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","volume":"12","author":"FC Kischkel","year":"2000","unstructured":"Kischkel, F.C. et al. Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611\u2013620 (2000).","journal-title":"Immunity"},{"key":"BFnm0302274_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","volume":"12","author":"MR Sprick","year":"2000","unstructured":"Sprick, M.R. et al. FADD\/MORT1 and Caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599\u2013609 (2000).","journal-title":"Immunity"},{"key":"BFnm0302274_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/35008667","volume":"2","author":"JL Bodmer","year":"2000","unstructured":"Bodmer, J.L. et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol. 2, 241\u2013243 (2000).","journal-title":"Nature Cell Biol."},{"key":"BFnm0302274_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","volume":"85","author":"M Boldin","year":"1996","unstructured":"Boldin, M., Goncharov, T., Goltsev, Y. & Wallach, D. Involvement of MACH, a novel MORT1\/FADD-interacting protease, in FAS\/APO-1-and TNF receptor-induced cell death. Cell 85, 803\u2013815 (1996).","journal-title":"Cell"},{"key":"BFnm0302274_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M Muzio","year":"1996","unstructured":"Muzio, M. et al. FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recurited to the CD95 (Fas\/APO1) death-inducing signaling complex. Cell 85, 817\u2013827 (1996).","journal-title":"Cell"},{"key":"BFnm0302274_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.281.5381.1317","volume":"281","author":"G Evan","year":"1998","unstructured":"Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317\u20131322 (1998).","journal-title":"Science"},{"key":"BFnm0302274_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng1097-141","volume":"17","author":"GS Wu","year":"1997","unstructured":"Wu, G.S. et al. KILLER\/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genet. 17, 141\u2013143 (1997).","journal-title":"Nature Genet."},{"key":"BFnm0302274_CR26","doi-asserted-by":"publisher","first-page":"22532","DOI":"10.1074\/jbc.274.32.22532","volume":"274","author":"C Scaffidi","year":"1999","unstructured":"Scaffidi, C. et al. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274, 22532\u201322538 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnm0302274_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"R Pitti","year":"1998","unstructured":"Pitti, R. et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699\u2013703 (1998).","journal-title":"Nature"},{"key":"BFnm0302274_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.190.7.1025","volume":"190","author":"M Djerbi","year":"1999","unstructured":"Djerbi, M. et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190, 1025\u20131031 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm0302274_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","volume":"190","author":"J Medema","year":"1999","unstructured":"Medema, J., de Jong, J., van Hall, T., Melief, C. & Offringa, R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190, 1033\u20131038 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm0302274_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi, A. et al. Safety and anti-tumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155\u2013162 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnm0302274_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86397","volume":"7","author":"D Lawrence","year":"2001","unstructured":"Lawrence, D. et al. Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions. Nature Med. 7, 383\u2013385 (2001).","journal-title":"Nature Med."},{"key":"BFnm0302274_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/86401","volume":"7","author":"JZ Qin","year":"2001","unstructured":"Qin, J.Z., Chaturvedi, V., Bonish, B. & Nickoloff, B.J. Avoiding premature apoptosis of normal epidermal cells. Nature Med. 7, 385\u2013386 (2001).","journal-title":"Nature Med."},{"key":"BFnm0302274_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0955-0674(99)80034-9","volume":"11","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi, A. & Dixit, V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255\u2013260 (1999).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnm0302274_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med. 5, 157\u2013163 (1999).","journal-title":"Nature Med."},{"key":"BFnm0302274_CR35","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1073\/pnas.030545097","volume":"97","author":"AM Chinnaiyan","year":"2000","unstructured":"Chinnaiyan, A.M. et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc. Natl. Acad. Sci. USA 97, 1754\u20131759 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0302274_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/bbrc.1999.1693","volume":"265","author":"W Roth","year":"1999","unstructured":"Roth, W. et al. Locoregional Apo2L\/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. 265, 1999 479\u2013483 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm0302274_CR37","first-page":"1362","volume":"7","author":"IF Pollack","year":"2001","unstructured":"Pollack, I.F., Erff, M. & Ashkenazi, A. Direct Stimulation of apoptotic signaling by soluble Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin. Cancer Res. 7, 1362\u20131369 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnm0302274_CR38","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.4049\/jimmunol.166.8.4891","volume":"166","author":"A Chuntharapai","year":"2001","unstructured":"Chuntharapai, A. et al. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J. Immunol. 166, 4891\u20134898 (2001).","journal-title":"J. Immunol."},{"key":"BFnm0302274_CR39","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/91000","volume":"7","author":"K Ichikawa","year":"2001","unstructured":"Ichikawa, K. et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nature Med. 7, 954 (2001).","journal-title":"Nature Med."},{"key":"BFnm0302274_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth. 139, 271\u2013279 (1991).","journal-title":"J. Immunol. Meth."},{"key":"BFnm0302274_CR41","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.275.5303.1122","volume":"275","author":"AM Chinnaiyan","year":"1997","unstructured":"Chinnaiyan, A.M., O'Rourke, K., Lane, B.R. & Dixit, V.M. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275, 1122\u20131126 (1997).","journal-title":"Science"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0302-274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0302-274","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0302-274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:05:19Z","timestamp":1684433119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0302-274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BFnm0302274"],"URL":"https:\/\/doi.org\/10.1038\/nm0302-274","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1004800.55554","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}